GSK’s decision to move its main research and development operation from Stevenage to Cambridge is creating uncertainty for a town...
Read moreNew CEO Sets Ambitious Growth Target Shares in Oxford Nanopore Technologies surged after newly appointed Chief Executive Officer Francis Van...
Read moreNovo Nordisk is expanding its efforts to reshape the weight-loss drug market by testing a lower-dose version of its Wegovy...
Read moreRegular walking may be one of the simplest ways to support brain health, and emerging research suggests that how much...
Read moreItalian biopharmaceutical company Kedrion is exploring a debt package of roughly $2 billion, with the proceeds potentially being used to...
Read moreAngola is signaling that it may look beyond Brazil for agricultural investment if existing cooperation does not deliver the scale...
Read moreEli Lilly is escalating its campaign against the growing black market for retatrutide, its experimental obesity drug, filing six lawsuits...
Read morePhilips is strengthening its relationship with Italy’s Agnelli family, with the family’s investment company Exor gaining the ability to increase...
Read morePharmaceutical giant increases its full-year revenue guidance after reporting strong demand for its blockbuster obesity and diabetes treatments, reinforcing confidence...
Read moreThis discusses self-harm. If you or someone you know is struggling, the 988 Suicide & Crisis Lifeline is available by...
Read more